![IHC-P analysis of human prostate carcinoma tissue using GTX28682 Prostatic Acid Phosphatase antibody [PASE/4LJ]. IHC-P analysis of human prostate carcinoma tissue using GTX28682 Prostatic Acid Phosphatase antibody [PASE/4LJ].](https://www.genetex.com/upload/website/prouct_img/normal/GTX28682/GTX28682_20191203_IHC-P_125_w_23060722_738.webp)
IHC-P analysis of human prostate carcinoma tissue using GTX28682 Prostatic Acid Phosphatase antibody [PASE/4LJ].
Prostatic Acid Phosphatase antibody [PASE-4LJ]
GTX28682
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetACP3
Overview
- SupplierGeneTex
- Product NameProstatic Acid Phosphatase antibody [PASE-4LJ]
- Delivery Days Customer9
- Application Supplier NoteIHC-P: 1:25-1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDPASE-4LJ
- ConjugateUnconjugated
- Gene ID55
- Target nameACP3
- Target descriptionacid phosphatase 3
- Target synonyms5'-NT, ACP-3, ACPP, TM-PAP, prostatic acid phosphatase, TMPase, acid phosphatase, prostate, ecto-5'-nucleotidase, prostatic acid phosphotase, protein tyrosine phosphatase ACP3, thiamine monophosphatase
- HostMouse
- IsotypeIgG1
- Protein IDP15309
- Protein NameProstatic acid phosphatase
- Scientific DescriptionThis gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced transcript variant encoding a longer isoform has been found for this gene. This isoform contains a transmembrane domain and is localized in the plasma membrane-endosomal-lysosomal pathway. [provided by RefSeq, Sep 2008]
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Gan Q, Joseph CT, Guo M, et al. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol. 2019,152(4):495-501. doi: 10.1093/ajcp/aqz063Read this paper
- Yang RK, Zhao P, Lu C, et al. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas. Hum Pathol. 2019,84:173-182. doi: 10.1016/j.humpath.2018.09.009Read this paper
- Giedl J, Büttner-Herold M, Wach S, et al. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma. Hum Pathol. 2016,55:101-7. doi: 10.1016/j.humpath.2016.04.016Read this paper
- Bastaki JM, Purgina BM, Dacic S, et al. Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors. Head Neck Pathol. 2014,8(3):250-60. doi: 10.1007/s12105-014-0518-8Read this paper
- Pistone G, Pistone A, Aricò M, et al. Multiple cutaneous metastases in the chest from prostatic carcinoma. Case Rep Dermatol. 2013,5(1):27-30. doi: 10.1159/000346801Read this paper


